Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
A observational or N/A phase clinical study on Cognitive Decline and GBA Gene Mutation, this trial is completed. The trial is conducted by National Institute of Neurological Disorders and Stroke (NINDS) and has accumulated 16 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Dec 2024 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Recruiting
-
Jan 2023 — Jul 2023 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Dec 2021 — Jan 2023 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
-
Sep 2018 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institutes of Health (NIH)
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .